Table 1.
Overview of Lipidomics Studies Used for Development and Validation of the SERRF Algorithm
study title, year | disease | ESI mode | no. samples: cohort/QC samples | no. of lipids |
---|---|---|---|---|
P20, 2016 | cardiovascular | (+) | 1162/125 | 401 |
(−) | 1162/126 | 268 | ||
GOLDN, 2018 | cardiovascular | (+) | 2696/288 | 418 |
(−) | 2692/280 | 366 | ||
ADNI, 2014 | Alzheimer’s | (+) | 832/83 | 501 |
(−) | 833/85 | 435 |